Results 111 to 120 of about 3,570 (199)

Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals [PDF]

open access: yes, 2015
Background Prazosin (PRZ, an α1-adrenergic receptor antagonist) and naltrexone (NTX, a non-specific opioid receptor antagonist) each decrease alcohol drinking when administered to rats selectively-bred for high voluntary alcohol drinking (alcohol ...
Froehlich, Janice C.   +2 more
core   +1 more source

Pharmacological management of unipolar depression

open access: yes, 2013
Objective : To be used in conjunction with ‘Psychological management of unipolar depression’ [Lampe et al. Acta Psychiatr Scand 2013;127(Suppl. 443):24–37] and ‘Lifestyle management of unipolar depression’ [Berk et al.
Berk, M.   +5 more
core   +2 more sources

Epilepsy and Psychiatric Comorbidities: Drug Selection. [PDF]

open access: yes, 2017
Purpose of review The pharmacological treatment of patients with epilepsy and psychiatric comorbidities may sometimes represent a therapeutic challenge.
A Thapar   +68 more
core   +1 more source

Duloksetins betydning for serumkonsentrasjonen av psykofarmaka som omsettes via CYP2D6 [PDF]

open access: yes, 2009
Bakgrunn: Duloksetin er et relativt nytt antidepressivum som hemmer reopptak av serotonin og noradrenalin intersynaptisk. Det metaboliseres via Cytokrom P450 2D6 (CYP2D6) og CYP1A2, men antas også å være en svak/moderat hemmer av CYP2D6.
Enoksen, Torill Bakko
core  

Antidepressants for pain management in adults with chronic pain: a network meta-analysis

open access: yesHealth Technology Assessment
Background Chronic pain is common and costly. Antidepressants are prescribed to reduce pain. However, there has not been a network meta-analysis examining all antidepressants across all chronic pain conditions, so effectiveness and safety for most ...
Hollie Birkinshaw   +9 more
doaj   +1 more source

Suicidality during treatment with serotonin and norepinephrine reuptake inhibitors

open access: yesEuropean Psychiatry
Introduction Treatment choice when prescribing antidepressants for major depressive disorder (MDD) is often influenced by safety and tolerability profiles.
I. Da Fonseca Pinto   +2 more
doaj   +1 more source

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Preparation of antidepressants for use in preclinical research [PDF]

open access: yes, 2007
Capello, Catherine   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy